LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Leukoencephalopathy
|
0.400 |
Biomarker
|
group |
HPO |
|
|
|
Malignant neoplasm of breast
|
0.310 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Azoospermia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Torticollis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Action Tremor
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormal saccadic eye movement
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Head tremor
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Primary hypogonadism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Sense of smell impaired
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of thalamus morphology
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormal motor neuron morphology
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Peripheral Nervous System Diseases
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Diabetes Mellitus, Experimental
|
0.200 |
Therapeutic
|
disease |
RGD |
Differential expression of hepatic sterol carrier proteins in the streptozotocin-treated diabetic rat.
|
7628371 |
1995 |
Infantile neuronal ceroid lipofuscinosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Assignment of sterol carrier protein X/sterol carrier protein 2 to 1p32 and its exclusion as the causative gene for infantile neuronal ceroid lipofuscinosis.
|
8004106 |
1994 |
Neurodegenerative Disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Consequently, it is unlikely that a mutation in SCPx/SCP2 is the underlying cause of this severe neurodegenerative disease of childhood.
|
8004106 |
1994 |
Adrenocortical carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The mRNA concentrations of SCP2 in two out of three adrenocortical carcinomas were relatively lower than those in other types of tissue.
|
8640304 |
1996 |
Refsum Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
A sterol-carrier protein-2 (SCP-2) knockout mouse model shares a similar clinical phenotype to Refsum's disease, but no mutations in SCP-2 have been described to-date in man.
|
11948235 |
2002 |
Cholesterol gallstones
|
0.020 |
Biomarker
|
disease |
BEFREE |
The SCP2 gene was overexpressed in patients with cholesterol gallstone, indicating that SCP2 may be one of the important causes of cholesterol gallstone.
|
15730934 |
2005 |
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Leukoencephalopathy
|
0.400 |
Biomarker
|
group |
CTD_human |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Dystonia
|
0.310 |
Biomarker
|
phenotype |
CTD_human |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |